‘ChatGPT for Doctors’ Startup Considers $6 Billion-Valuation Investment

OpenEvidence, which operates a ChatGPT-like product for doctors to find health information, is considering multiple investment offers valuing the three-year-old startup at $6 billion, nearly double its private valuation from a financing just one month ago, according to three people involved in the potential deal.

The funding conversations are still in their early stages. If a deal happens, the company is likely to raise more than $100 million, one of the people involved said. The funding interest comes as ChatGPT creator OpenAI gears up to develop products related to the healthcare sector and other health-related artificial intelligence startups make inroads into selling their products to doctors and other medical professionals.